Gw, You once told me that with a complete phase III of Rituxan, and everything ready at the FDA, just few months before approval was too big a chance to take and selling the Rituxan royalties was justify,
the Rituxan royalties, were sold for $17 millions, Blue how much Rituxan sales in the last 4 years, close to $2 billions, and the sales will go up to $2 billion per year when they add Rheumatoid Arthritis and Lupus, xoma ex-royalties were 3%? or 5%? any body remember!
just this year at 3% (of $800 millions?) $15 MILLIONS of PURE NET PROFIT giving away (oops...sold) to keep growing and 15 more years of patent protection, almost $250 millions (and it could go to $500 millions total, without compounding the money just take and expend) for $17 million dollars
And now you are so hopeful for a completely non proven and non sense phaseI/II researcher sponsored (not even xoma is willing to pay for it) trial to get the little children their drug and approval for orphan drug designation?
Sorry, I can not comprehend !!! |
